Research: Chinese Covid-19 vaccine shows promising trial results


BEIJING, Aug 16 (Xinhua): An inactivated Covid-19 vaccine candidate developed by China is safe and generates an immune response, according to data from clinical trials published in The Journal of the American Medical Association this week.

The research paper provided an interim analysis of the phase-1 and phase-2 clinical trials of an inactivated Covid-19 vaccine developed by the Wuhan Institute of Biological Products under the China National Biotec Group (CNBG), affiliated to Sinopharm, and the Wuhan Institute of Virology under the Chinese Academy of Sciences.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Aseanplus News

Space station crew returns to Earth after six months
Restarted nuclear reactor encounters glitch
Defence satellite for military ops launched amid regional tensions
Fines handed out to owners of polluting vehicles
Bolstering Seoul’s defences
Schools shut over hazardous air quality
‘Ashes and stones everywhere’
Junta chief to make first China visit
At least 36 dead after bus falls into ravine
Signing up as a ‘big loser’

Others Also Read